Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-02-28Clinical Trial Update: Docetaxel Alone or in Combination With Enzalutamide for mCRPC Previously Treated With Abiraterone at mHSPC Stage [Phase 2, Phase 3]
A clinical trial evaluating docetaxel alone or with enzalutamide for metastatic castration-resistant prostate cancer previously treated with…
-
CLINICAL_TRIALS trial_result · 2024-02-28Clinical Trial Update: Stereotactic Body Radiotherapy With or Without Darolutamide for OligoRecurrent Prostate Cancer [Phase 2]
Phase 2 trial update investigating stereotactic body radiotherapy with or without darolutamide for oligorecurrent prostate cancer.
-
CLINICAL_TRIALS trial_result · 2024-02-28Clinical Trial Update: CASCARA: Castration Sensitive Carboplatin, Cabazitaxel and Abiraterone [Phase 2]
Phase 2 clinical trial update for CASCARA combining castration sensitivity strategies with carboplatin, cabazitaxel, and abiraterone in pros…
-
CLINICAL_TRIALS trial_result · 2024-02-26Clinical Trial Update: Ultrasound Guided Inguinal Indocyanine Green Injection to Identify and Pre-emptively Seal Lymphatic Leaks [Phase 4]
Phase 4 clinical trial update examining ultrasound-guided indocyanine green injection to identify and seal lymphatic leaks in lymphocele and…
-
CLINICAL_TRIALS trial_result · 2024-02-22Clinical Trial Update: SpaceOAR System RWS in China [NA]
Boston Scientific's SpaceOAR System real-world study in China for localized prostate cancer has completed and results were posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-02-21Clinical Trial Update: Study of High-dose Rate (HDR) Monotherapy for Low and Intermediate Risk Prostate Cancer [Phase 2]
Phase 2 trial update on high-dose-rate monotherapy for low and intermediate risk prostate cancer.
-
CLINICAL_TRIALS trial_result · 2024-02-20Clinical Trial Update: ADXS31-142 Alone and in Combination With Pembrolizumab (MK-3475) in Participants With Previously Treated Metastatic Castration-Resistant Prostate Cancer (mCRPC) [Phase 1, Phase 2]
Phase 1/2 trial of ADXS31-142 alone and with pembrolizumab in previously treated metastatic castration-resistant prostate cancer completed; …
-
CLINICAL_TRIALS trial_result · 2024-02-20Clinical Trial Update: Radiation and Adebrelimab in Prostate Cancer With Imaging-measurable Disease (RAPID) [Phase 2]
Phase 2 clinical trial update examining radiation plus adebrelimab in metastatic castration-resistant prostate cancer with imaging-measurabl…
-
CLINICAL_TRIALS trial_result · 2024-02-15Clinical Trial Update: 68Ga PSMA in Preprostatectomy Patients [Phase 2, Phase 3]
A completed Phase 2/Phase 3 clinical trial evaluating 68Ga PSMA in preprostatectomy patients for prostate cancer; results posted in 2024.
-
CLINICAL_TRIALS trial_result · 2024-02-15Clinical Trial Update: 18F-DCFPyL Positron Emission Tomography (PET) in Intermediate or High Risk Prostate Cancer [Phase 2]
Phase 2 clinical trial evaluating 18F-DCFPyL PET imaging in intermediate/high risk prostate cancer; study terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2024-02-14Clinical Trial Update: Study of HPN424 in Patients With Advanced Prostate Cancer [Phase 1, Phase 2]
Phase 1/2 trial of HPN424 in advanced prostate cancer has been terminated; results posted in 2024.
-
CLINICAL_TRIALS trial_result · 2024-02-13Clinical Trial Update: Sex-Mismatched Allogeneic Bone Marrow Transplantation for Men With Metastatic Castration-Resistant Prostate Cancer [Phase 1]
Phase 1 clinical trial evaluating sex-mismatched allogeneic bone marrow transplantation in men with metastatic castration-resistant prostate…
-
CLINICAL_TRIALS trial_result · 2024-02-07Clinical Trial Update: Safety and Efficacy of [18F]PSMA-1007 Injection in Suspected Persistent or Recurrent Prostate Cancer. [Phase 3]
Phase 3 trial evaluating safety and efficacy of [18F]PSMA-1007 injection for suspected persistent or recurrent prostate cancer has completed…
-
CLINICAL_TRIALS trial_result · 2024-02-07Clinical Trial Update: Prostate Cancer Intensive, Non-Cross Reactive Therapy (PRINT) for Castration Resistant Prostate Cancer (CRPC) [Phase 2]
Phase 2 trial update for intensive, non-cross reactive therapy in castration-resistant prostate cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2024-02-07Clinical Trial Update: Radiotherapy Combined With a LHRH (Ant)Agonist Versus Apalutamide in Patients With Biochemical Recurrence After RP [Phase 2]
Phase 2 trial comparing radiotherapy plus LHRH agonist vs apalutamide in patients with biochemical recurrence after radical prostatectomy fo…
-
CLINICAL_TRIALS trial_result · 2024-02-06Clinical Trial Update: PRAGMA (Prostate Radio Ablation Guided by Magnetic Resonance Imaging Acquisition) in Metastatic Prostate Cancer [NA]
A completed clinical trial (PRAGMA) evaluating MRI-guided prostate radioablation in metastatic prostate cancer; results posted in 2024.
-
CLINICAL_TRIALS trial_result · 2024-02-01Clinical Trial Update: HDR Brachytherapy 68-Ga-RM2 PET, 68-Ga-PSMA-11 PET &Multi Parametric MRI in Prostate Cancer [Phase 2]
Phase 2 clinical trial update for HDR brachytherapy using 68-Ga-RM2 PET, 68-Ga-PSMA-11 PET, and multiparametric MRI in prostate cancer; tria…
-
CLINICAL_TRIALS trial_result · 2024-02-01Clinical Trial Update: Safety and Pharmacokinetics of ODM-209 [Phase 1, Phase 2]
Phase 1/2 trial update on safety and pharmacokinetics of ODM-209 for metastatic prostate cancer and advanced/metastatic breast cancer.
-
CLINICAL_TRIALS trial_result · 2024-01-31Clinical Trial Update: Anti-Androgens and Cabazitaxel in Defining Complete Response in Prostatectomy (ACDC Trial) [Phase 2]
Phase 2 clinical trial update evaluating anti-androgens and cabazitaxel in defining complete response after prostatectomy for prostate cance…
-
CLINICAL_TRIALS trial_result · 2024-01-30Clinical Trial Update: Gallium Ga 68 DOTA-NeoBOMB1 and Gallium Ga 68 PSMA-R2 PET/MRI in Diagnosing Participants With Recurrent Prostate Cancer [Phase 2]
Phase 2 trial update evaluating Gallium-68 DOTA-NeoBOMB1 and Gallium-68 PSMA-R2 PET/MRI for diagnosing recurrent prostate cancer with PSA pr…
-
CLINICAL_TRIALS trial_result · 2024-01-30Clinical Trial Update: Self-Administered Nitrous Oxide (SANO) During Transrectal Prostate Biopsy to Reduce Patient Anxiety and Pain [Phase 4]
Phase 4 trial evaluating self-administered nitrous oxide to reduce anxiety and pain during transrectal prostate biopsy; study completed with…
-
CLINICAL_TRIALS trial_result · 2024-01-30Clinical Trial Update: 68-Ga PSMA 11 PET/MRI and 68-Ga RM2 PET/MRI for Evaluation of Prostate Cancer Response to HIFU Therapy [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating 68-Ga PSMA-11 PET/MRI and 68-Ga RM2 PET/MRI for monitoring prostate cancer response to HIFU therapy; res…
-
CLINICAL_TRIALS trial_result · 2024-01-24Clinical Trial Update: The Metformin Active Surveillance Trial (MAST) Study [Phase 3]
A Phase 3 clinical trial update for the Metformin Active Surveillance Trial (MAST) in prostate cancer is reported with unknown status.
-
CLINICAL_TRIALS trial_result · 2024-01-24Clinical Trial Update: Radium-223 Combined With Dexamethasone as First-line Therapy in Patients With M+CRPC [Phase 4]
Phase 4 trial update investigating Radium-223 combined with dexamethasone as first-line therapy for metastatic castration-resistant prostate…
-
CLINICAL_TRIALS trial_result · 2024-01-19Clinical Trial Update: Prostate Advances in Comparative Evidence [Phase 3]
Phase 3 clinical trial update for prostate cancer within the Prostate Advances in Comparative Evidence program.